Biosynth extends its array of GMP-compliant peptide synthesis services, tailored to cater to both peptide NCEs and commercial peptides.
Harmonizing Innovative Peptide Science with Adaptable GMP Manufacturing Expertise
With an emphasis on precision and scalability, Biosynth’s capabilities encompass a streamlined and expanded drug substance manufacturing process, meticulously tailored to seamlessly integrate into clinical trials (in accordance with EudraLex, volume 4, part II), facilitated by their state-of-the-art facility in the Netherlands.
- Boasting a commendable track record and flexible GMP manufacturing prowess.
- Ensuring efficiency through rapid timelines across distinct production phases.
- Incorporating a tried-and-true template that encompasses meticulous process execution, analytical methodologies, and comprehensive documentation.
- Leveraging synthesis protocols optimized by experts steeped in the intricacies of peptide chemistry.
- Comprehensive range of QC analyses conducted under stringent GMP guidelines, alongside rigorous stability testing.
- Offering seamless upscaling services to adapt to evolving project demands.
To learn more, please complete the Quick Contact form or email: firstname.lastname@example.org